Samsung Biologics Co.,Ltd. (KRX:207940)

Samsung Biologics Statistics

Total Valuation

KRX:207940 has a market cap or net worth of KRW 79.16 trillion. The enterprise value is 78.62 trillion.

Market Cap	79.16T
Enterprise Value	78.62T

Important Dates

The last earnings date was Wednesday, January 21, 2026.

Earnings Date	Jan 21, 2026
Ex-Dividend Date	n/a

Share Statistics

KRX:207940 has 46.29 million shares outstanding.

Current Share Class	46.29M
Shares Outstanding	46.29M
Shares Change (YoY)	n/a
Shares Change (QoQ)	n/a
Owned by Insiders (%)	0.01%
Owned by Institutions (%)	12.81%
Float	11.83M

Valuation Ratios

The trailing PE ratio is 49.04 and the forward PE ratio is 45.63. KRX:207940's PEG ratio is 1.47.

PE Ratio	49.04
Forward PE	45.63
PS Ratio	17.37
PB Ratio	10.62
P/TBV Ratio	10.62
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	1.47

Enterprise Valuation

EV / Earnings	44.07
EV / Sales	17.25
EV / EBITDA	n/a
EV / EBIT	37.98
EV / FCF	n/a

Financial Position

The company has a current ratio of 1.74, with a Debt / Equity ratio of 0.12.

Current Ratio	1.74
Quick Ratio	0.57
Debt / Equity	0.12
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on Equity (ROE)	n/a
Return on Assets (ROA)	n/a
Return on Invested Capital (ROIC)	17.18%
Return on Capital Employed (ROCE)	24.27%
Weighted Average Cost of Capital (WACC)	5.33%
Revenue Per Employee	955.35M
Profits Per Employee	374.00M
Employee Count	4,770
Asset Turnover	0.32
Inventory Turnover	n/a

Taxes

In the past 12 months, KRX:207940 has paid 505.00 billion in taxes.

Income Tax	505.00B
Effective Tax Rate	23.83%

Stock Price Statistics

The stock price has decreased by -4.74% in the last 52 weeks. The beta is 0.21, so KRX:207940's price volatility has been lower than the market average.

Beta (5Y)	0.21
52-Week Price Change	-4.74%
50-Day Moving Average	1,752.00
200-Day Moving Average	1,642.00
Relative Strength Index (RSI)	40.82
Average Volume (20 Days)	65,387

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, KRX:207940 had revenue of KRW 4.56 trillion and earned 1.78 trillion in profits. Earnings per share was 38,538.85.

Revenue	4.56T
Gross Profit	2.52T
Operating Income	2.07T
Pretax Income	2.12T
Net Income	1.78T
EBITDA	n/a
EBIT	2.07T
Earnings Per Share (EPS)	38,538.85

Balance Sheet

The company has 1.46 trillion in cash and 919.00 billion in debt, with a net cash position of 537.00 billion or 11,600.54 per share.

Cash & Cash Equivalents	1.46T
Total Debt	919.00B
Net Cash	537.00B
Net Cash Per Share	11,600.54
Equity (Book Value)	7.45T
Book Value Per Share	160,960.19
Working Capital	1.88T

Cash Flow

Operating Cash Flow	n/a
Capital Expenditures	n/a
Free Cash Flow	n/a
FCF Per Share	n/a

Margins

Gross margin is 55.23%, with operating and profit margins of 45.42% and 39.15%.

Gross Margin	55.23%
Operating Margin	45.42%
Pretax Margin	46.50%
Profit Margin	39.15%
EBITDA Margin	n/a
EBIT Margin	45.42%
FCF Margin	n/a

Dividends & Yields

KRX:207940 does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	n/a
Shareholder Yield	n/a
Earnings Yield	2.25%
FCF Yield	n/a

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value
Lynch Upside
Graham Number
Graham Upside

Stock Splits

The last stock split was on October 30, 2025. It was a reverse split with a ratio of 0.6503913.

Last Split Date	Oct 30, 2025
Split Type	Reverse
Split Ratio	0.6503913

Scores

KRX:207940 has an Altman Z-Score of 14.63 and a Piotroski F-Score of 5.

Altman Z-Score	14.63
Piotroski F-Score	5